Abstract
The potential for gastrointestinal ulcers and bleeding is the major limiting factor in the use of nonsteroidal anti-inflammatory drugs (NSAIDs). Various treatment strategies -- ranging from the use of anti-inflammatory drugs that are associated with fewer adverse events to medical cotherapy to prevent ulcer disease -- have been proposed to reduce risks for upper GI events in NSAID users. Investigators used a decision-tree model …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
